1. Home
  2. ARMP vs FNWB Comparison

ARMP vs FNWB Comparison

Compare ARMP & FNWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARMP
  • FNWB
  • Stock Information
  • Founded
  • ARMP N/A
  • FNWB 1923
  • Country
  • ARMP United States
  • FNWB United States
  • Employees
  • ARMP N/A
  • FNWB N/A
  • Industry
  • ARMP Biotechnology: Biological Products (No Diagnostic Substances)
  • FNWB Banks
  • Sector
  • ARMP Health Care
  • FNWB Finance
  • Exchange
  • ARMP Nasdaq
  • FNWB Nasdaq
  • Market Cap
  • ARMP 92.4M
  • FNWB 79.5M
  • IPO Year
  • ARMP N/A
  • FNWB 2015
  • Fundamental
  • Price
  • ARMP $2.61
  • FNWB $8.01
  • Analyst Decision
  • ARMP Strong Buy
  • FNWB Hold
  • Analyst Count
  • ARMP 1
  • FNWB 1
  • Target Price
  • ARMP $9.00
  • FNWB $12.00
  • AVG Volume (30 Days)
  • ARMP 9.3K
  • FNWB 24.2K
  • Earning Date
  • ARMP 08-12-2025
  • FNWB 07-24-2025
  • Dividend Yield
  • ARMP N/A
  • FNWB 3.46%
  • EPS Growth
  • ARMP N/A
  • FNWB N/A
  • EPS
  • ARMP N/A
  • FNWB N/A
  • Revenue
  • ARMP $6,868,000.00
  • FNWB $48,874,000.00
  • Revenue This Year
  • ARMP $8.43
  • FNWB $35.06
  • Revenue Next Year
  • ARMP N/A
  • FNWB $13.06
  • P/E Ratio
  • ARMP N/A
  • FNWB N/A
  • Revenue Growth
  • ARMP 84.67
  • FNWB N/A
  • 52 Week Low
  • ARMP $0.90
  • FNWB $6.05
  • 52 Week High
  • ARMP $2.96
  • FNWB $12.10
  • Technical
  • Relative Strength Index (RSI)
  • ARMP 58.67
  • FNWB 51.40
  • Support Level
  • ARMP $2.43
  • FNWB $7.99
  • Resistance Level
  • ARMP $2.72
  • FNWB $8.43
  • Average True Range (ATR)
  • ARMP 0.18
  • FNWB 0.25
  • MACD
  • ARMP -0.01
  • FNWB 0.03
  • Stochastic Oscillator
  • ARMP 70.08
  • FNWB 49.40

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It includes deposit and lending transactions that are supplemented with other borrowing and investing activities. The bank's principal lending activities are focused on first lien one- to four-family mortgage loans, commercial and multi-family real estate loans, construction and land loans, commercial business loans, and consumer loans.

Share on Social Networks: